Price $27.44 |
Market Cap
524.5M
|
Sector Health Care |
Div. Growth
15.80%
|
|
P/E
27.0
|
P/B
4.35
|
P/S
5.08
|
Dividend %
1.00%
|
|
P/CF
-
|
P/FCF
32.4
|
Op. Cash Flow
24.1K
|
FCF
0.8
|
|
Op. Margin
21.10%
|
Net Margin
17.20%
|
ROE
15.80%
|
ROI
15.30%
|
|
ROA
13.90%
|
EPS Growth
27.30%
|
Current Ratio
6.1
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Sangamo Therapeutics Inc (SGMO) | $10.74 | - | - | 1.42B | Strong Buy |
| InfuSystem Holdings Inc (INFU) | $3.49 | - | - | 61.1M | Strong Buy |
| Correvio Pharma Corp (CORV) | $3.26 | - | - | 122.4M | Strong Buy |
| Aquinox Pharmaceuticals Inc (AQXP) | $2.20 | - | - | 63.8M | Strong Buy |
| Quorum Health Corp (QHC) | $4.13 | - | - | 140.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
